A. Titapun

发表

In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines

N. Khuntikeo, Jutarop Phetcharaburanin, P. Klanrit, 2020, Drug design, development and therapy.

Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program.

A. Suwannatrai, W. Loilome, Kavin Thinkhamrop, 2024, Asian Pacific journal of cancer prevention : APJCP.

Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand

A. Wee, N. Khuntikeo, Julaluck Promsorn, 2022, Frontiers in Oncology.

Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma

H. Saya, Jutarop Phetcharaburanin, P. Klanrit, 2022, Frontiers in Pharmacology.

Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand.

A. Wee, N. Khuntikeo, Julaluck Promsorn, 2022, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand

N. Khuntikeo, Julaluck Promsorn, W. Loilome, 2022, Frontiers in Public Health.

Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression

N. Khuntikeo, Jutarop Phetcharaburanin, P. Klanrit, 2021, Frontiers in Pharmacology.

Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma

H. Saya, N. Khuntikeo, Jutarop Phetcharaburanin, 2020, Journal of Translational Medicine.

Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth

N. Khuntikeo, P. Yongvanit, A. Techasen, 2018, Oncology letters.

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway

P. Yongvanit, A. Techasen, N. Namwat, 2018, OncoTargets and therapy.

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the Pi3K/pakt pathway

P. Yongvanit, A. Techasen, N. Namwat, 2018 .

Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms

N. Khuntikeo, Raynoo Thanan, A. Techasen, 2021, Diagnostics.

Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia

N. Khuntikeo, N. Chamadol, B. Thinkhamrop, 2018, Front. Med..

Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma.

N. Khuntikeo, P. Yongvanit, A. Techasen, 2016, Anticancer research.

Benign Diseases Masquerading as Cholangiocarcinoma: Can we Differentiate before Surgery?

C. Pairojkul, N. Khuntikeo, V. Bhudhisawasdi, 2022, Asian Pacific Journal of Cancer Care.

Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse

C. Isidoro, N. Khuntikeo, N. Namwat, 2020, Cancers.

Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells

Jutarop Phetcharaburanin, P. Klanrit, N. Namwat, 2023, PeerJ.

A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients.

N. Khuntikeo, N. Chamadol, V. Laopaiboon, 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.

1H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism

N. Khuntikeo, N. Chamadol, Jutarop Phetcharaburanin, 2023, PeerJ.

Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy

C. Isidoro, P. Yongvanit, A. Techasen, 2019, Journal of traditional and complementary medicine.

CD44 variant‐dependent redox status regulation in liver fluke‐associated cholangiocarcinoma: A target for cholangiocarcinoma treatment

S. Okazaki, Shinya Abe, T. Masuko, 2016, Cancer science.

Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of Opisthorchis viverrini-Associated Cholangiocarcinoma at Early Cancer Stage

J. Chindaprasirt, A. Techasen, P. Klanrit, 2023, Cancers.

Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy

P. Yongvanit, A. Techasen, N. Namwat, 2018, FEBS open bio.

Interleukin 25 (IL-25) expression in cholangiocarcinoma

T. Limpaiboon, Siriporn Proungvitaya, Attapol Titapun, 2020, Molecular and clinical oncology.

Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool

Raynoo Thanan, P. Yongvanit, Wassana Jamnongkan, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma

J. Chindaprasirt, N. Khuntikeo, J. Lim, 2021, Diagnostics.

Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand

A. Wee, N. Khuntikeo, Julaluck Promsorn, 2022, Frontiers in Medicine.

CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression

H. Saya, N. Khuntikeo, Jutarop Phetcharaburanin, 2021, PloS one.